What We Fund
APDA has been a funding partner in many major scientific breakthroughs and has awarded more than $55 million in research grants to date.
APDA maintains eight Centers for Advanced Research and individual research grants and fellowships are awarded annually for promising research by experienced and young scientists. Grants are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board (SAB). The SAB is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to Parkinson’s disease research.
APDA provides sponsorship support for select professional education opportunities to foster and encourage the sharing of ideas, knowledge and possibilities among PD professionals.
A proud funder of Parkinson’s Researchers
Available Parkinson’s Research Funding Opportunities
Centers for Advanced Research are located in major academic and medical centers across the country intended to strengthen and help to integrate already existing investigative teams. These Centers receive funding to support large research programs which include: research trainees; fellowship programs; early stage discovery programs and later stage clinical translation. These Centers facilitate research which is at the forefront of investigation into the causes, treatments and ultimately the cure(s) for Parkinson’s disease.
Dr. George C. Cotzias Memorial Fellowship George C. Cotzias, MD was a pathfinder in the pharmacologic exploration of brain functions and in the treatment of Parkinson’s disease with levodopa. His work stimulated much of the current interest and research on neurological movement disorders. The American Parkinson Disease Association has established the Cotzias fellowship, in honor of his memory, to stimulate neurologists to follow his leadership. The goal of the Cotzias fellowship is to assist promising young neurologists in establishing careers in research, teaching and clinical services relevant to the problems, causes, prevention, diagnosis and treatment of Parkinson’s disease and related neurological movement disorders. This is a fellowship is for three years and is not renewable.
Post-Doctoral Fellowships are awarded to support post-doctoral scientists whose research holds promise to provide new insights into the pathophysiology, etiology and treatment of Parkinson’s disease. This is a fellowship for two years.
Research Grants are awarded to investigators affiliated with and performing Parkinson’s disease research at major academic institutions across the United States. This is a grant for one year, renewable.
Diversity in Parkinson’s Disease Research Grant is awarded to support a research scientist studying the health disparities and/or differences among under-studied PD communities. This is a grant for one year.
Read the latest articles on Parkinson’s research
Questions About Parkinson’s Disease & Cognitive Impairment Changes in cognition can unfortunately be a common non-motor symptom of Parkinson’s disease (PD). Mild cognitive impairment (MCI) is an early stage of cognitive difficulty that does not interfere with a person’s ability to perform activities independently but can nevertheless affect a person’s performance of more complex cognitive […]
What the latest science tells us about probiotics & Parkinson’s disease People often ask us about the use of probiotics to improve Parkinson’s disease (PD) symptoms. Probiotics have gained a lot of popularity in recent years, but what exactly are they, and can they make a difference for people with PD? I will answer these […]
On September 8, 2022, APDA announced 27 new research grants for the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease (PD) to develop new treatments and eventually, a cure. We are honored to support our researcher’s work. We awarded $2.35 million to support cutting-edge PD research for the 2022-2023 year […]
Potential new medications for Parkinson’s cognitive decline With Parkinson’s disease (PD), cognitive issues are quite common. Yet, there are currently few medications available to help alleviate this troubling symptom. In the recent past, there were a scarcity of clinical trials testing potential medications for cognitive difficulties and PD. Currently, there is now a long list […]